278 related articles for article (PubMed ID: 18775044)
1. Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.
Hu YF; Chen YC; Cheng CC; Higa S; Chen YJ; Chen SA
J Cardiovasc Electrophysiol; 2009 Feb; 20(2):200-6. PubMed ID: 18775044
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-mediated nonadrenergic noncholinergic relaxation of piglet pulmonary arteries decreases with postnatal age.
Gonzáles-Luis G; Fletcher AJ; Moreno L; Pérez-Vizcaíno F; Blanco CE; Villamor E
J Physiol Pharmacol; 2007 Mar; 58(1):45-56. PubMed ID: 17440225
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase isoform inhibition before whole body ischemia reperfusion in pigs: vital or protective?
Adams JA; Wu D; Bassuk J; Arias J; Lozano H; Kurlansky P; Lamas GA
Resuscitation; 2007 Sep; 74(3):516-25. PubMed ID: 17466432
[TBL] [Abstract][Full Text] [Related]
5. Posttranslational activation of endothelial nitric oxide synthase attenuates carbon tetrachloride-induced hepatotoxicity in newborn rats.
Liu H; Subramony C; Nowicki M
Pediatr Res; 2008 Jun; 63(6):613-9. PubMed ID: 18317400
[TBL] [Abstract][Full Text] [Related]
6. Electromechanical effects of the direct renin inhibitor (aliskiren) on the pulmonary vein and atrium.
Tsai CF; Chen YC; Lin YK; Chen SA; Chen YJ
Basic Res Cardiol; 2011 Nov; 106(6):979-93. PubMed ID: 21779913
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin prevents oxidized low-density lipoprotein-induced injury of renal tubular epithelial cells by inhibiting the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Chu G; Jia R; Yang D
J Nephrol; 2006; 19(3):286-95. PubMed ID: 16874687
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
[TBL] [Abstract][Full Text] [Related]
9. Cariporide (HOE642) attenuates lactic acidosis induced pulmonary vein arrhythmogenesis.
Udyavar AR; Chen YC; Cheng CC; Higa S; Chen YJ; Chen SA
Life Sci; 2009 Jul; 85(1-2):19-25. PubMed ID: 19422839
[TBL] [Abstract][Full Text] [Related]
10. ATX-II-induced pulmonary vein arrhythmogenesis related to atrial fibrillation and long QT syndrome.
Lu YY; Cheng CC; Chen YC; Chen SA; Chen YJ
Eur J Clin Invest; 2012 Aug; 42(8):823-31. PubMed ID: 22339387
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells.
Aoki C; Nakano A; Tanaka S; Yanagi K; Ohta S; Jojima T; Kasai K; Takekawa H; Hirata K; Hattori Y
Int J Cardiol; 2012 Apr; 156(1):55-61. PubMed ID: 21093076
[TBL] [Abstract][Full Text] [Related]
12. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules.
Mueck AO; Seeger H; Wallwiener D
Exp Clin Endocrinol Diabetes; 2001; 109(3):181-3. PubMed ID: 11409302
[TBL] [Abstract][Full Text] [Related]
13. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
14. Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling.
Madonna R; De Caterina R
Thromb Haemost; 2009 Feb; 101(2):345-50. PubMed ID: 19190820
[TBL] [Abstract][Full Text] [Related]
15. Involvement of endogenous nitric oxide in the regulation of K+ channel activity in cultured human proximal tubule cells.
Nakamura K; Habano W; Kojo T; Komagiri Y; Kubota T; Kubokawa M
J Physiol Sci; 2006 Dec; 56(6):407-13. PubMed ID: 17062169
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran and thrombin modulate electrophysiological characteristics of pulmonary vein and left atrium.
Chang CJ; Chen YC; Kao YH; Lin YK; Chen SA; Chen YJ
Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1176-83. PubMed ID: 23118275
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells.
Xenos ES; Stevens SL; Freeman MB; Cassada DC; Goldman MH
Ann Vasc Surg; 2005 May; 19(3):386-92. PubMed ID: 15818460
[TBL] [Abstract][Full Text] [Related]
18. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
[TBL] [Abstract][Full Text] [Related]
20. Reduction of myocardial infarct size by fluvastatin.
Tiefenbacher CP; Kapitza J; Dietz V; Lee CH; Niroomand F
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H59-64. PubMed ID: 12623790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
